To shorten monopoly periods for prescription drugs that are the subjects of sudden price hikes.
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line